If you’re over age 40 and you notice that words are starting to seem blurrier when you read, you’re not going crazy. There’s a good chance you’re experiencing presbyopia. Presbyopia is an age-related, ...

Presbyopia is an age-related medical condition whereby a person loses the ability to see objects at near distance clearly. Everyone will develop presbyopia at some point in their lives. Even if one ...

Please provide your email address to receive an email when new articles are posted on . Noninvasive or minimally invasive approaches may be the solution for presbyopia before the onset of age-related ...

SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (LENZ) (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial biopharmaceutical company focused on the development and ...

The MarketWatch News Department was not involved in the creation of this content. The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

- Investigational, novel eye drop candidate was assigned PDUFA goal date of October 22, 2023 PONTE VEDRA, Fla., Feb. 21, 2023 /PRNewswire/ -- Orasis Pharmaceuticals, an emerging ophthalmic ...

ATHERTON, Calif., November 17, 2025--(BUSINESS WIRE)--TearOptix, Inc., a pioneering contact lens company developing advanced solutions for patients with presbyopia, today announced the completion of a ...

DUBLIN--(BUSINESS WIRE)--The "Global Myopia and Presbyopia Treatment Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The market for myopia and presbyopia treatment is ...

Picture this: You've settled into your favorite reading spot after a long day, steaming cup of tea in hand, ready to dive into that page-turner you've been looking forward to all week. But first, you ...

LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lunatus Marketing & Consulting FZCO (“Lunatus”) today announced an exclusive distribution agreement for Lunatus to register and commercialize VIZZ TM for the ...